Serological biomarkers detect active joint destruction and inflammation in patients with haemophilic arthropathy.
Baolai HuaE H N OlsenS SunC N GudmeL WangB VandahlK RoepstorffM Kjelgaard-HansenB B SørensenY ZhaoM A KarsdalTina Manon-JensenPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2017)
Biomarkers detect increased cartilage and bone degradation, and altered inflammatory activity in haemophilia patients with arthropathy. These biomarkers could potentially be used to identify patients with progressing joint disease.
Keyphrases